FP

Flagship Pioneering Portfolio holdings

AUM $268M
This Quarter Return
-6.06%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$2.38B
AUM Growth
+$2.38B
Cap. Flow
+$44.3M
Cap. Flow %
1.86%
Top 10 Hldgs %
99.67%
Holding
12
New
–
Increased
2
Reduced
1
Closed
–

Top Buys

1
MCRB icon
Seres Therapeutics
MCRB
$56.1M
2
CDAK
Codiak BioSciences, Inc. Common Stock
CDAK
$728K

Top Sells

1
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$12.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRNA icon
1
Moderna
MRNA
$9.37B
$1.52B 64.14% 12,886,743 – –
SANA icon
2
Sana Biotechnology
SANA
$777M
$205M 8.65% 34,239,018 – –
MCRB icon
3
Seres Therapeutics
MCRB
$166M
$148M 6.25% 23,117,045 +8,738,243 +61% +$56.1M
OMGA
4
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$140M 5.91% 25,902,269 – –
FHTX icon
5
Foghorn Therapeutics
FHTX
$286M
$109M 4.58% 12,674,120 – –
EVLO
6
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$105M 4.44% 50,427,328 – –
DNLI icon
7
Denali Therapeutics
DNLI
$2.23B
$80.4M 3.38% 2,619,968 – –
AXLA
8
DELISTED
Axcella Health Inc. Common Stock
AXLA
$32.3M 1.36% 18,867,785 – –
RUBY
9
DELISTED
Rubius Therapeutics, Inc
RUBY
$16.6M 0.7% 38,506,526 – –
SYRS
10
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$6.4M 0.27% 993,848 -1,944,646 -66% -$12.5M
SGTX
11
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$5.19M 0.22% 10,370,369 – –
CDAK
12
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$2.76M 0.12% 3,540,636 +933,333 +36% +$728K